Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Every investor here is well aware of the fact that a clinical stage biopharma is going to sell shares in order to fund operations from now until they have a revenue generating drug. We aren't investing into Oncolix because of their current balance sheet, we are investing because of the potential of Prolanta. This is so simple and it boils down to Prolanta and nothing else. If the drug works, everyone here makes money, if it doesn't, no one makes money. Pointing out things that are normal for every company that is pre-revenue and trying to make a negative argument out of them is really really dumb. You have a better argument when comparing Prolanta vs Novartis' LFA102, but it's a weak argument at best as they aren't even close to similar.
I think it's time for some new material and maybe a new angle? Just some thoughts.
Yeah that particular agreement and the terms of the deal ended in August 2016 as part of the $1.5 million investment by BioVectra into Oncolix. Oncolix still maintains BioVectra as a manufacturer of Prolanta. And there is no need for a filing as a manufacturer of a drug is not something that requires an 8k. Sorry.
BioVectra is the contract manufacturer, not sure why that is in question. Where are you getting your information that the agreement ran out? I'd like to see a source for that.
Go Redman! He's doing a fantastic job! Things just keeping on moving forward as planned!
Where should we have our Oncolix investor success party? I know most people will say Vegas and I'm completely fine with that.
You need to read through that document again. Redman has been deferring his income for years.
Apparently people believe Oncolix executives are supposed to work for free, receive free advertising, get free tickets to events, get drugs manufactured for free, get free clinical trials, etc... Is this the new American dream where everything is free?
Redmans salary is deferred. Also $300k is well below the industry average.
Check out what the officers of Innovation Pharmaceuticals make and they don't produce any revenue:
https://imgur.com/gallery/risa5
Yeah the link is right there....
****BREAKING NEWS****
Oncolix Government Trials Website has been Updated 2/14/2018.
Status: Recruiting
Estimated Primary Completion Date: February 2019. <-------------------
https://imgur.com/gallery/juZ5f
IT LOOKS LIKE THE TRIALS HAVEN'T CONCLUDED BUT IN FACT ARE STILL ON GOING
Not sure if they are aware of it or don't believe it, but legal action is on the horizon. Not sure these efforts against Oncolix will be worth it when all is said and done. Lawyers tend to be expensive.
Pretty crazy stuff being thrown around on this board. Redman and Dr Youkey were in the same kindergarten class together. They always dreamed of growing up and running a biopharma enrichment scam.
Great post! Bravo!
Redman could pay himself $5m per year and if we get solid trial results, guess what?....... the PPS is still going up. So don't get fooled into thinking that this stock's success will be determined by anything other than Prolanta trial results.
It really is that simple. Until we have evidence that the trials aren't going to happen or that the drug isn't going to work, we have no reason to sell. We're holding for results, which judging by the science, look very promising.
KISS
Keep It Simple Stupid
At the end of the day it doesn't matter about what executives get paid or any of this other BS people keep talking about. All that matters is trial results. Trial results are what this stock boils down to. They could max out the 950m AS, but if we have solid trial results the PPS is still going up up up. Everything that happens with the stock price and what is said on this board until trial results is WHITE NOISE. None of it matters. The efficacy of Prolanta is the only thing that will determine how successful Oncolix will be.
You have no clue. Oncolix isn't doing anything wrong. They are running exactly the same way every other clinical stage biopharma is running. No one is being robbed or fleeced. We are supporting and investing in a company with a legitimate potential breakthrough cancer treatment. Yes we all know there will be some shares being sold in order to pay for trials and business operations. That's the reason why companies go public (DUHHHH). They are taking out notes as needed. They aren't going to dilute this company into ground, they've taken out enough to cover them through phase I. Everyone is expecting phase I results to be a major catalyst. Major catalysts cause the price to increase and when the price increases the less shares that are needed to be sold in order to fund subsequent trials and operations. Also, it gives investors an opportunity to liquidate positions with profits.
This is how things are going to go down. You throw words around like dilution in attempt to scare people, but anyone who knows anything about clinical stage biopharma's knows that some dilution is necessary. If people can't handle a little dilution then this isn't a stock for them. We all know with a strong enough catalyst, it won't matter. Price will increase. The float here is a miniscule 33m.
This is a legit company. Period.
You guys have such a weak argument it's not even funny. It's completely reliant on non-factual information and your delusional ideas of what you think is happening. When you actually do thorough research and fact finding, it's easy to poke holes in such flawed ideas trying to be passed along as facts.
Redman has a proven track record and over 30 years of experience in the industry. I'm more than comfortable with him taking a salary that is well below the industry average for a CEO of a biopharma company. Also, his salary needs to be approved by the board of directors and most notably GHS who works with top of line biopharma companies all the time. They know what CEO's get paid as well as the ins and outs of the business. Oncolix is in good hands. One of the most legitimate plays in the OTC.
It's funny that you say Novartis is a real company. Look what company is being highlighted and listed with Novartis:
http://www.itor-ghs.org/pharmaceutical-industry.php
Go ONCX!!!
Not only is the Novartis drug completely different from Prolanta, it's also being tested on a completely different cancer. Comparing the 2 drugs is really a dumb thing to do since they are 100% different im every single way.
Novartis' LFA102 is not even close to the same as Oncolix G129R.
LFA102 is a monoclonal antibody, which are antibodies produced by a single clone of cells or cell line and consisting of identical antibody molecules.
G129R (Prolanta) is a prolactin receptor antagonist with a single amino acid mutation, which substitutes the 129th position on the peptide chain.
G120R (Somavert) is a human growth hormone receptor antagonist with a single amino acid mutation, which substitutes the 120th position on the peptide chain.
Human growth hormone and prolactin are both pituitary hormones of the same cytokine receptor family. They share 49 of their amino acid residues in identical positions on the peptide chain.
Can you now see how Prolanta and Somavert are more closely related than Prolanta and LFA102? The Novartis method is inferior to Prolanta which has precedent from its sibling drug known as Somavert.
Wen Chen developed both Prolanta and Somavert in the same manner. LFA102 is a completely different method of action which Wen Chen has nothing to do with. This is like comparing marijuana to opiates in terms of pain relief. Different methods of action and different drugs.
IMO
And positive phase I results showing safety and efficacy are EXPECTED. With this float and OS, $1+ PPS is very possible. Second cohort of phase I testing is EXPECTED to start anytime within the next 6-7 weeks. We are VERY VERY close.
HUGE THINGS ARE ABOUT TO HAPPEN HERE
I can't wait til phase I trials are concluded. It's guaranteed to yield positive results. Prolanta is essentially the same exact drug as Somavert, Which happens to be FDA approved. Prolanta will atleast get to phase III with a high probability of an FDA approval.
Scientists have been trying for years to counteract human prolactin with various drugs and most notably bromocriptine, because they know it plays a huge role in the development and spread of tumors as well as chemo resistance. Prolanta is the first pure prolactin antagonist designed and modeled off of Somavert the first pure growth hormone antagonist.
Growth hormone and prolactin share 49 identical amino acid residues along their peptide chains. Somavert aka G120R is an amino acid substitution of 120th amino acid residue position and Prolanta aka G129R is an amino acid substitution of the 129th amino acid residue position. These are 2 of the 49 identical positions that are shared by hGH and hPRL.
Knowing that a near identical drug, Somavert, has successfully made it through FDA trials as a pure hGH antagonist, it's almost a guarantee that Prolanta will make it through FDA trials as a pure hPRL antagonist. Both hGH and hPRL are pituitary hormones that are part of the same cytokine receptor family.
A near identical drug working on a near identical hormone. Smells like Prolanta success!!!
BIG THINGS COMING!!!
GO ONCX!!!
Failed? Where is your source for that information? How can something fail that is still in trials?
I'd love to hear this explanation.
Nice edit! Hahaha
Weak. Lol.
What makes you so confident that there's no hope for these cancer patients? Phase I still needs to be completed before anyone can make any sort of assumptions like that. Things are just getting started here.
The company is far from worthless. There is a ton of potential value in Prolanta, the science and initial results of their Xenograft and first cohort of human trials have been more than encouraging. Also, why on earth would you compare a biopharma CEO salary to average US occupation salaries? That's like comparing oranges to rocks.
$300k is actually pretty low for CEO's in the cancer drug biopharma sector. Innovation Pharmaceuticals doesn't produce any revenue and they are paying their officers $465k per year. The average CEO in this industry and sector is making well into the millions.
Nothing to see here folks, just standard business practices.
Seriously? No one here expects Oncolix to produce any revenue until an FDA approved drug hits the market. This is simple stuff. No one here is being tricked or duped. We all understand what's going on. We are investing in the future potential of Prolanta. You do realize if Oncolix had a revenue producing FDA cancer treatment on the market, they would be trading in the $20-$50 range right? This is a pre-revenue microcap biopharma. Nothing out of the ordinary is happening here.
LMFAO
More like a rookie mistake by a rookie investor who has no clue how to read filings or any idea about how clinical stage biopharma's operate. Pretty laughable stuff going on here. I find the amateur hour bafoonery to be pretty entertaining. I'll just back with my bowl of popcorn and smile.
No the Greenville Health System. They go by a different name now though.
Patient dosing to begin in the 1st quarter of the year. So anytime from now until the end of March. In my opinion that's pretty big news and we are at most 7 weeks away from it.
According the US trials government website, the trial has no concluded and is still in a status of recruiting which coincides with their latest PR. Are you maybe looking at the wrong companies trial page? It's the only explanation for your blatant inaccuracies.
What are you even talking about? The transfer agent updated the SS only a couple of days ago and it has remained unchanged since the merger. Stop the lies.
All we need from the IR team right now are updates on the trial. Hopefully that starts this month and it would be nice to get preliminary data as the trials progresses on as well.
Trials haven't ended and according to the US Government trial site it is in a status of recruiting which coincides with their latest PR's. An estimated completion date is not a firm deadline. Also where are you getting these outrageous debt numbers from?
Again, GHS is the majority owner of Oncolix. Nothing can be done without their consent. So unless they all of sudden become corrupt, Oncolix is going to be just fine.
IMO
You can't pass someone's blog off as DD. I'm sorry but that's not going to cut it.
I'm not going to lie, I m guessing those links have become dead since the Oncolix legal team is getting involved. No need to have old lawsuits where people were found innocent to still be floating around the internet.
Oncolix legal is clearly taking action. Good for them!
That's the gold standard for DD right there. LOLOLOLOLOLOL!!!!